Danaher Corporation — Beckman Coulter
Tracked across 3 events · 18 articles · First seen Apr 13, 2026 · Last active Aug 20, 2026
Live sentiment trends, attention charts, and prominence tracking available on the
Ergen Dashboard
Tech
Impact: Danaher Corporation — Beckman Coulter, a subsidiary of Danaher Corporation, received CE 2797 mark for its Access MeMed BV assay, enabling broad availability of the test in Europe. This development is expected to enhance its market position in diagnostics.
Apr 13, 2026 · 6 articles
Business
Multiple market research reports project significant growth in the global hematology analyzers and reagents market over the next several years. MarketsandMarkets forecasts growth from USD 7.57 billion in 2026 to USD 10.33 billion by 2031,…
Impact: Subsidiary of Danaher; key player in analyzers.
Jul 08, 2026 · 6 articles
Business
Impact: Danaher Corporation — Beckman Coulter is among the prominent players driving innovation and competition in the chemiluminescence immunoassay analyzer market.
Jun 05, 2026 · 6 articles
ERGEN INTELLIGENCE
Track Danaher Corporation — Beckman Coulter live
Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.
Open Dashboard